1) therapeutic protein
医用蛋白质
1.
To date, many recombinant therapeutic proteins such as antibodies, vaccines and human hormone have been produced by genetic transformed tobacco, and most of them have been applied to human and animal health care.
至今,已有多种医用蛋白质,如单克隆抗体、疫苗、人体外激素等通过转基因烟草生产出来,其临床应用及大田栽培试验正在进行。
2) protein medical polymers
蛋白质类医用高分子
3) glycosyl proteins
[医]糖化蛋白质
4) protein utilization
蛋白质利用
1.
36)?kg of mean body weight were allocated into control and treatment group randomly and the treatment pigs were injected with GHRP-2 intramuscularly at the dose of 30?μg/kgBW respectively every day for 15 days to investigate the the growth performance and protein utilization, then to investigate the growth performance in the following 15 days without injection.
将10头初始体重为(26·55±1·36)kg的DLY生长猪平均随机分成对照组和处理组,处理组连续15d每天每头猪按体重分别肌肉注射30μg/kg的GHRP-2,对照组注射同体积生理盐水,考察GHRP-2对试猪生产性能和蛋白质利用及GH水平的影响。
2.
Three experiments were conducted to determine the optimum enzymolysis conditions of porcine blood, to estimate the ileum ammo acid apparent digestibility of enzymolyzed porcine blood meal, and to evaluate the effects of enzymolyzed porcine blood meal on protein utilization and growth performance of early weaned piglets.
本文研究了猪血适宜的酶解参数，并考察了酶解血粉回肠氨基酸表观消化率，以及酶解血粉对早期断奶仔猪蛋白质利用和生产性能的影响。
5) fibrin sealant
医用生物蛋白胶
1.
Immunogenicity of fibrin sealant and its main component fibrinogen;
医用生物蛋白胶及其主体成分纤维蛋白原的免疫原性研究
2.
Neurologic evaluation of α-cyanoacrylate medical adhesive and fibrin sealant in rats;
α-氰基丙稀酸酯医用胶和医用生物蛋白胶对大鼠神经功能的影响
3.
Part Ⅰ the process of NGF released byfibrin sealantcontaining NGFPurpose: To specify the releasing velocity of NGF carried by fibrin sealant in vitro.
第一部分医用生物蛋白胶释放神经生长因子(NGF)的过程 目的：明确以医用生物蛋白胶为载体的NGF体外释放速度。
6) biomedical fibrin glue
医用生物蛋白胶
1.
Objective: To investigate the feasibility of biomedical fibrin glue in cholecystectomy.
目的:探讨医用生物蛋白胶在胆囊切除手术中的应用效果。
补充资料：医用纤维蛋白黏合剂
分子式：
CAS号：
性质：从人体血浆中提取的黏合剂。由两种液剂组成：一种含血纤维蛋白原，凝血因子VIII，抑肽酶或氨基乙酸；另一种含有凝血酶及氯化钙溶液。其固化反应直接利用了人体自身的凝血机制，最终生成粘接力很强的血纤维蛋白网络。调和后2min，其粘接强度可达最终强度的70％，30～90min内达最大值5.5～6MPa，其有效粘接力可维持2周左右。黏合剂在血浆酶的作用下将被机体完全降解吸收，此时创口完全愈合。它适用于自身凝血机能障碍或服用抗凝血药物患者的止血，易撕裂组织如肝、脾等的黏合，显微外科中代替缝合等
CAS号：
性质：从人体血浆中提取的黏合剂。由两种液剂组成：一种含血纤维蛋白原，凝血因子VIII，抑肽酶或氨基乙酸；另一种含有凝血酶及氯化钙溶液。其固化反应直接利用了人体自身的凝血机制，最终生成粘接力很强的血纤维蛋白网络。调和后2min，其粘接强度可达最终强度的70％，30～90min内达最大值5.5～6MPa，其有效粘接力可维持2周左右。黏合剂在血浆酶的作用下将被机体完全降解吸收，此时创口完全愈合。它适用于自身凝血机能障碍或服用抗凝血药物患者的止血，易撕裂组织如肝、脾等的黏合，显微外科中代替缝合等
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条